Mr Vuong Nguyen

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Nguyen, V., Daien, V., Guymer, R., Young, S., Hunyor, A., Fraser-Bell, S., Hunt, A., Gillies, M., Barthelmes, D. (2019). Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration. Ophthalmology, 126(1), 64-74. [More Information]
  • Barthelmes, D., Nguyen, V., Walton, R., Gillies, M., Daien, V. (2018). A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013�2016. The Fight Retinal Blindness! Project. Graefe's Archive for Clinical and Experimental Ophthalmology, 256(10), 1839-1846. [More Information]
  • Mehta, H., Hennings, C., Gillies, M., Nguyen, V., Campain, A., Fraser-Bell, S. (2018). Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. Cochrane Database of Systematic Reviews, 2018 (4), 1-70. [More Information]
  • Nguyen, V., Daien, V., Guymer, R., McAllister, I., Morlet, N., Barthelmes, D., Gillies, M. (2018). Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term observational data set. The Fight Retinal Blindness! Project. Clinical and Experimental Ophthalmology, 46(3), 266-274. [More Information]
  • Invernizzi, A., Nguyen, V., Arnold, J., Young, S., Barthelmes, D., Gillies, M. (2018). Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology, 125(2), 237-244. [More Information]
  • Daien, V., Nguyen, V., Essex, R., Morlet, N., Barthelmes, D., Gillies, M. (2018). Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration. Ophthalmology, 125(1), 66-74. [More Information]
  • Greenville, A., Nguyen, V., Wardle, G., Dickman, C. (2018). Making the most of incomplete long-term datasets: the MARSS solution. Australian Zoologist, 39(4), 733-747. [More Information]
  • Daien, V., Nguyen, V., Morlet, N., Arnold, J., Essex, R., Young, S., Hunyor, A., Gillies, M., Barthelmes, D. (2018). Outcomes and predictive factors after cataract surgery in patients with neovascular age-related macular degeneration The Fight Retinal Blindness! Project. American Journal of Ophthalmology, 190, 50-57. [More Information]
  • Lowry, E., Nguyen, V., Daien, V., Barthelmes, D., Gillies, M. (2018). Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational Study. Ophthalmology Retina, 2(6), 531-538. [More Information]
  • Vaze, A., Nguyen, V., Daien, V., Arnold, J., Young, S., Cheung, C., Lamoureux, E., Bhargava, M., Barthelmes, D., Gillies, M. (2018). RANIBIZUMAB AND AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Data from an Observational Study. Retina, 38(10), 1954-1961. [More Information]
  • Mehta, H., Tufail, A., Daien, V., Lee, A., Nguyen, V., Ozturk, M., Barthelmes, D., Gillies, M. (2018). Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Progress in Retinal and Eye Research, 65, 127-146. [More Information]
  • Ozturk, M., Harris, M., Nguyen, V., Barthelmes, D., Gillies, M., Mehta, H. (2018). Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence. Clinical and Experimental Ophthalmology, 46(4), 407-411. [More Information]
  • Invernizzi, A., Nguyen, V., Gillies, M. (2018). Relationship between reticular pseudodrusen and choroidal thickness in intermediate age-related macular degeneration: comment. Clinical and Experimental Ophthalmology, 46(8), 966-967. [More Information]
  • Mehta, H., Fraser-Bell, S., Nguyen, V., Lim, L., Gillies, M. (2018). Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema. British Journal of Ophthalmology, 102(4), 479-482. [More Information]
  • Barthelmes, D., Nguyen, V., Daien, V., Campain, A., Walton, R., Guymer, R., Morlet, N., Hunyor, A., Essex, R., Arnold, J., Gillies, M. (2018). Two Year Outcomes Of "Treat And Extend" Intravitreal Therapy Using Aflibercept Preferentially For Neovascular Age-Related Macular Degeneration. Retina, 38(1), 20-28. [More Information]
  • Gillies, M., Daien, V., Nguyen, V., Barthelmes, D. (2017). Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et�al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761). Ophthalmology, 124(3), e31-e32. [More Information]
  • Barthelmes, D., Campain, A., Nguyen, V., Arnold, J., McAllister, I., Simpson, J., Hunyor, A., Guymer, R., Essex, R., Morlet, N., Gillies, M. (2016). Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration. British Journal of Ophthalmology, 100(12), 1640-1645. [More Information]
  • Kim, L., Mehta, H., Barthelmes, D., Nguyen, V., Gillies, M. (2016). Metaanalysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration. Retina: the Journal of Retinal and Vitreous Diseases, 36(8), 1418-1431. [More Information]
  • Greenville, A., Wardle, G., Nguyen, V., Dickman, C. (2016). Population dynamics of desert mammals: similarities and contrasts within a multispecies assemblage. Ecosphere, 7(5), 1-19. [More Information]
  • Greenville, A., Wardle, G., Nguyen, V., Dickman, C. (2016). Spatial and temporal synchrony in reptile population dynamics in variable environments. Oecologia, 182(2), 475-485. [More Information]
  • Essex, R., Nguyen, V., Walton, R., Arnold, J., McAllister, I., Guymer, R., Morlet, N., Young, S., Barthelmes, D., Gillies, M. (2016). Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration. Ophthalmology, 123(11), 2393-2400. [More Information]
  • Gillies, M., Nguyen, V., Daien, V., Arnold, J., Morlet, N., Barthelmes, D. (2016). Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study. Ophthalmology, 123(12), 2545-2553. [More Information]
  • Nguyen, V., Greenville, A., Dickman, C., Wardle, G. (2015). On the validity of visual cover estimates for time series analyses: a case study of hummock grasslands. Plant Ecology, 216(7), 975-988. [More Information]

2019

  • Nguyen, V., Daien, V., Guymer, R., Young, S., Hunyor, A., Fraser-Bell, S., Hunt, A., Gillies, M., Barthelmes, D. (2019). Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration. Ophthalmology, 126(1), 64-74. [More Information]

2018

  • Barthelmes, D., Nguyen, V., Walton, R., Gillies, M., Daien, V. (2018). A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013�2016. The Fight Retinal Blindness! Project. Graefe's Archive for Clinical and Experimental Ophthalmology, 256(10), 1839-1846. [More Information]
  • Mehta, H., Hennings, C., Gillies, M., Nguyen, V., Campain, A., Fraser-Bell, S. (2018). Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. Cochrane Database of Systematic Reviews, 2018 (4), 1-70. [More Information]
  • Nguyen, V., Daien, V., Guymer, R., McAllister, I., Morlet, N., Barthelmes, D., Gillies, M. (2018). Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term observational data set. The Fight Retinal Blindness! Project. Clinical and Experimental Ophthalmology, 46(3), 266-274. [More Information]
  • Invernizzi, A., Nguyen, V., Arnold, J., Young, S., Barthelmes, D., Gillies, M. (2018). Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology, 125(2), 237-244. [More Information]
  • Daien, V., Nguyen, V., Essex, R., Morlet, N., Barthelmes, D., Gillies, M. (2018). Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration. Ophthalmology, 125(1), 66-74. [More Information]
  • Greenville, A., Nguyen, V., Wardle, G., Dickman, C. (2018). Making the most of incomplete long-term datasets: the MARSS solution. Australian Zoologist, 39(4), 733-747. [More Information]
  • Daien, V., Nguyen, V., Morlet, N., Arnold, J., Essex, R., Young, S., Hunyor, A., Gillies, M., Barthelmes, D. (2018). Outcomes and predictive factors after cataract surgery in patients with neovascular age-related macular degeneration The Fight Retinal Blindness! Project. American Journal of Ophthalmology, 190, 50-57. [More Information]
  • Lowry, E., Nguyen, V., Daien, V., Barthelmes, D., Gillies, M. (2018). Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational Study. Ophthalmology Retina, 2(6), 531-538. [More Information]
  • Vaze, A., Nguyen, V., Daien, V., Arnold, J., Young, S., Cheung, C., Lamoureux, E., Bhargava, M., Barthelmes, D., Gillies, M. (2018). RANIBIZUMAB AND AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Data from an Observational Study. Retina, 38(10), 1954-1961. [More Information]
  • Mehta, H., Tufail, A., Daien, V., Lee, A., Nguyen, V., Ozturk, M., Barthelmes, D., Gillies, M. (2018). Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Progress in Retinal and Eye Research, 65, 127-146. [More Information]
  • Ozturk, M., Harris, M., Nguyen, V., Barthelmes, D., Gillies, M., Mehta, H. (2018). Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence. Clinical and Experimental Ophthalmology, 46(4), 407-411. [More Information]
  • Invernizzi, A., Nguyen, V., Gillies, M. (2018). Relationship between reticular pseudodrusen and choroidal thickness in intermediate age-related macular degeneration: comment. Clinical and Experimental Ophthalmology, 46(8), 966-967. [More Information]
  • Mehta, H., Fraser-Bell, S., Nguyen, V., Lim, L., Gillies, M. (2018). Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema. British Journal of Ophthalmology, 102(4), 479-482. [More Information]
  • Barthelmes, D., Nguyen, V., Daien, V., Campain, A., Walton, R., Guymer, R., Morlet, N., Hunyor, A., Essex, R., Arnold, J., Gillies, M. (2018). Two Year Outcomes Of "Treat And Extend" Intravitreal Therapy Using Aflibercept Preferentially For Neovascular Age-Related Macular Degeneration. Retina, 38(1), 20-28. [More Information]

2017

  • Gillies, M., Daien, V., Nguyen, V., Barthelmes, D. (2017). Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et�al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761). Ophthalmology, 124(3), e31-e32. [More Information]

2016

  • Barthelmes, D., Campain, A., Nguyen, V., Arnold, J., McAllister, I., Simpson, J., Hunyor, A., Guymer, R., Essex, R., Morlet, N., Gillies, M. (2016). Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration. British Journal of Ophthalmology, 100(12), 1640-1645. [More Information]
  • Kim, L., Mehta, H., Barthelmes, D., Nguyen, V., Gillies, M. (2016). Metaanalysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration. Retina: the Journal of Retinal and Vitreous Diseases, 36(8), 1418-1431. [More Information]
  • Greenville, A., Wardle, G., Nguyen, V., Dickman, C. (2016). Population dynamics of desert mammals: similarities and contrasts within a multispecies assemblage. Ecosphere, 7(5), 1-19. [More Information]
  • Greenville, A., Wardle, G., Nguyen, V., Dickman, C. (2016). Spatial and temporal synchrony in reptile population dynamics in variable environments. Oecologia, 182(2), 475-485. [More Information]
  • Essex, R., Nguyen, V., Walton, R., Arnold, J., McAllister, I., Guymer, R., Morlet, N., Young, S., Barthelmes, D., Gillies, M. (2016). Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration. Ophthalmology, 123(11), 2393-2400. [More Information]
  • Gillies, M., Nguyen, V., Daien, V., Arnold, J., Morlet, N., Barthelmes, D. (2016). Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study. Ophthalmology, 123(12), 2545-2553. [More Information]

2015

  • Nguyen, V., Greenville, A., Dickman, C., Wardle, G. (2015). On the validity of visual cover estimates for time series analyses: a case study of hummock grasslands. Plant Ecology, 216(7), 975-988. [More Information]

To update your profile click here. For support on your academic profile contact .